Accelerating the execution of key contracts can be mission critical for biotech and pharma companies.

External GC Law Group, LLC provides fractional GC-level legal services on contracts to biotech and pharma companies in Massachusetts.  External GC’s clients range in size and stage, including early-stage “stealth” companies to those initiating clinical trials and those commercializing approved products.

Scott B. Townsend, Esq., our Managing Partner, has +25 years of public biotech and pharma company and law firm experience.  He served as General Counsel or Chief Corporate Counsel of three public companies (VYGR, AMAG and CRTX). He also served as a corporate transactional lawyer at top tier law firms such as WilmerHale and Goodwin working on M&A, venture financing and public offerings.

Mr. Townsend has advised life science clients regarding the day-to-day business and legal issues, including contract negotiations, including CDAs/NDAs, consulting agreements, CMO/CDMO agreements, CRO agreements, clinical trial agreements, licensing and technology transfer matters.

Founded in 2010, External GC provides fractional GC-level legal work for life science companies and, when requested, can help clients manage the legal services provided by traditional outside AM Law 100 law firms.

Our clients appreciate paying a fraction of the cost of either hiring a full-time general counsel or relying exclusively on traditional outside law firms.

For more information, please contact our Managing Partner by clicking here.